L, I., S, S., FS, M. M., H, T., JC, T., MN, G. Q., . . . M, S. (2025). Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab. Scientific reports, 15(1), 8815. https://doi.org/10.1038/s41598-025-93094-2
Chicago Style (17th ed.) CitationL, Incorvaia, et al. "Sex as Modifier of Survival in Patients with Advanced Urothelial Cancer Treated with Pembrolizumab." Scientific Reports 15, no. 1 (2025): 8815. https://doi.org/10.1038/s41598-025-93094-2.
MLA (9th ed.) CitationL, Incorvaia, et al. "Sex as Modifier of Survival in Patients with Advanced Urothelial Cancer Treated with Pembrolizumab." Scientific Reports, vol. 15, no. 1, 2025, p. 8815, https://doi.org/10.1038/s41598-025-93094-2.
Warning: These citations may not always be 100% accurate.
